# The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity

> **NCT06540573** · — · NOT_YET_RECRUITING · sponsor: **Gaziosmanpasa Research and Education Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Osteoarthritis

## Interventions

- **DIAGNOSTIC_TEST:** Laboratory tests (examination)
- **DIAGNOSTIC_TEST:** Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index
- **DIAGNOSTIC_TEST:** The Disease Activity Score28 (DAS28)
- **DIAGNOSTIC_TEST:** Patient global assessment (PGA)
- **DIAGNOSTIC_TEST:** Physician global assessment (PhGA)
- **DIAGNOSTIC_TEST:** Health Assessment Questionnaire (HAQ)
- **DIAGNOSTIC_TEST:** Clinical disease activity index (CDAI)
- **DIAGNOSTIC_TEST:** The Simplified Disease Activity Index (SDAI)
- **DIAGNOSTIC_TEST:** Knee Radiography

## Key facts

- **NCT ID:** NCT06540573
- **Lead sponsor:** Gaziosmanpasa Research and Education Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08-12
- **Primary completion:** 2024-11-15
- **Final completion:** 2024-11-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06540573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06540573, "The Relationship Between Serum Chemokine Ligand 21 (CCL-21) Level and Disease Activity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06540573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*